Trial Profile
Safety and efficacy study of rhAngiostatin administered in combination with paclitaxel and carboplatin to patients with non-small-cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2006
Price :
$35
*
At a glance
- Drugs Angiostatin (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors EntreMed
- 03 Nov 2006 Status change
- 10 Aug 2005 New trial record.